TPO and essential thrombocythemia: In patients with myeloproliferative disorders such as essential thrombocythemia (ET), studies have shown an impaired platelet‐dependent TPO clearance, suggesting that thrombocytosis in ET may be attributed to an alteration in TPO signalling via its receptor c‐MPL.16